Evidence of Effective Drug Delivery using Transdermal Gel Delivery Systems in Cats. Your email here: Subject 1. Clinic State Choose OneALAKASAZARCACOCTDEDCFMFLGAGUHIIDILINIAKSKYLAMEMHMDMAMIMNMSMOMTNENVNHNJNMNYNCNDMPOHOKORPWPAPRRISCSDTNTXUTVTVIVAWAWVWIWY (2-letter - ex. Alabama = AL) 2. City Population Choose One<50005,001-10,00010,001-25,00025,001-50,00050,001-100,000100,001-250,000250,000-500,000>500,000 3. Number of Patients Seen Annually: Choose One<5,000, 5-10,00016-20,00021-25,00026-30,00031-40,00041-50,00051-75,000<75,000 4. Feline Breed: Domestic shorthair Domestic mediumhair Domestic longhair Abyssinian Burmese Himalayan Mancoon Persian Russian Blue Rex Siamese Other 4a. If other, please state breed: 5. Weight of Cat: (please specify unit - kg or lb) 6. Gender of Cat: Female intact Female spayed Male intact Male castrated 7. Age of Cat: Choose One<0.50.5-11.1-33.1-55.1-7.57.6-1010.1-12.512.6-15>15 8. Which drug preparation is this cat receiving? Amitryptylline Buprenorphine Enrofloxacin Methimazole Metronidazole Prednisolone Prednisone 9. How is the drug administered? As A Transdermal Gel Orally - Tablet Orally - Syrup Orally - Capsule Other 10. Regarding the drug preparation, choose the best descriptor: finished(approved)brand-name dosing form finished(approved)generic dosing form compounded in-house compounded by a local pharmacist compounded by an internet pharmacist 11. If you selected a transdermal gel (TDG) product for this animal, what was this decision based on: (select all that apply) 1) Anticipated client compliance 2) Client request 3) Cost 4) Fractious pet 5) Intolerance to oral medication 6) Previous successful outcome 11a. Based on your selection(s) above, which one was most important in your decision to use a TDG? 1) Anticipated client compliance 2) Client request 3) Cost 4) Fractious pet 5) Intolerance to oral medication 12. Site of treatment for transdermal gel? inside pinna abdomen other 12a. What is the dosage (please specify mg/kg)? 12b. What is the frequency of dosing each day? sid (once per day) bid (twice per day) tid (three times per day) qid (four times per day) prn (as needed) other 13. For what condition is this medication prescribed? (select all that apply) Allergy Behavioral modification Dysuria Pain Management Immune Mediated Disease Infection Inflammation Hyperthyroidism IBD Other 13a. If other, please describe: 13b. What is the specific diagnosis? 13c. If you selected "Pain Management" in 13, please state source and location of pain: 14. How long has the cat received this medication? (please specify days/weeks) 15. How has the patient responded to this drug? Choose OneWorsenedNo ChangeSlight ImprovementFair ImprovementGood ImprovementExcellent Improvement 16. Is this cat receiving any other medications? If so, please describe, including the duration of treatment 17. Indicate the timing of your peak sample collection (hrs post administration): 1 2 3 4 5 6 18. Indicate the timing of your trough sample collection (hrs post administration): 9 10 11 12 14 20 21 22 23 24 other 18a. If other, please describe: 19. What is the date that this drug preparation was compounded? 20. What is the cited expiration date of this preparation? 21. What are the recommended storage conditions for this preparation? 22. Please provide preferred contact information below: (can include name, phone, etc.) Contact information is necessary in case the study investigators have question about the submitted data or results of sample analysis. Please include your clinic name and phone number here. 23. Please list any other drugs prescribed as transdermal gels that you would like to have tested?